Skip to main content

Table 3 Comparison in laboratory results between patients with plaque regression and progression

From: Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study

  Regression Progression P-value
N=180 N=28
WBC (cells/μl) 9323 ± 3443 9635 ± 1878 0.5
Max CK (IU/L) 1852 ± 1993 1717 ± 1629 0.7
Hb (g/dL) 14.1 ± 1.6 13.7 ± 1.9 0.3
AST (IU/L) 80.2 ± 102.8 79.2 ± 86.9 0.96
ALT (IU/L) 33.9 ± 22.5 35.2 ± 22.4 0.8
γ-GTP (IU/L) 45.7 ± 52.3 57.2 ± 68.3 0.4
Total bilirubin (mg/dL) 0.8 ± 0.3 0.8 ± 0.3 0.2
BUN (mg/dL) 15.3 ± 4.9 15.4 ± 5.2 0.9
Creatinine (mg/dL) 0.81 ± 0.24 0.83 ± 0.19 0.7
Uric acid (mg/dL) 5.4 ± 1.6 5.1 ± 1.7 0.4
TC (mg/dL) 196.1 ± 36.5 196.3 ± 35.4 0.98
LDL-C (mg/dL) 132.1 ± 33.3 131.4 ± 34.0 0.9
TG (mg/dL) 115.2 ± 53.0 115.1 ± 24.0 0.99
HDL-C (mg/dL) 44.0 ± 10.3 45.7 ± 8.8 0.4
RLP-C (mg/dL) 4.2 ± 2.3 4.0 ± 2.3 0.6
hs-CRP(mg/L) 32.8 ± 39.0 48.8 ± 43.9 0.08
FBS (mg/dL) 153.6 ± 61.8 156.9 ± 63.8 0.8
HbA1c (%) 6.3 ± 1.2 6.9 ± 1.7 0.023
AGEs (U/mL) 8.4 ± 2.2 9.4 ± 1.9 0.032
sRAGE (pg/mL) 683 (496–1037) 723 (483–1081) 0.9
  1. WBC, white blood cell counts; CK, creatine kinase; Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-guanosine 5’-triphosphate; BUN, blood urea nitrogen; TC, total cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; FBS, fasting blood sugar; HbA1c, haemoglobin A1c; AGEs, Advanced glycation end products; sRAGE, serum Receptor of AGE.
  2. Data were expressed as the mean ± SD or median (IQR).